These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22935973)

  • 1. Altered IκBα expression promotes NF-κB activation in monocytes from primary Sjögren's syndrome patients.
    Lisi S; Sisto M; Lofrumento DD; D'Amore M
    Pathology; 2012 Oct; 44(6):557-61. PubMed ID: 22935973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective feedback regulation of NF-kappaB underlies Sjogren's syndrome in mice with mutated kappaB enhancers of the IkappaBalpha promoter.
    Peng B; Ling J; Lee AJ; Wang Z; Chang Z; Jin W; Kang Y; Zhang R; Shim D; Wang H; Fleming JB; Zheng H; Sun SC; Chiao PJ
    Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15193-8. PubMed ID: 20696914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary gland expression level of IκBα regulatory protein in Sjögren's syndrome.
    Sisto M; Lisi S; Lofrumento DD; Ingravallo G; De Lucro R; D'Amore M
    J Mol Histol; 2013 Aug; 44(4):447-54. PubMed ID: 23377923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Xinfeng Capsule reduces hypercoagulative state in patients with Sjogren's syndrome by inhibiting miR-155/SOCS1/NF-κB signaling pathway].
    Zhu F; Liu J; Wang G; Fang L; Zhang P; Tan B
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Oct; 32(10):1366-1371. PubMed ID: 27667464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local and Systemic IKKε and NF-κB Signaling Associated with Sjögren's Syndrome Immunopathogenesis.
    Chen W; Lin J; Cao H; Xu D; Xu B; Xu L; Yue L; Sun C; Wu G; Qian W
    J Immunol Res; 2015; 2015():534648. PubMed ID: 26380323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IkappaBalpha promoter polymorphisms in patients with primary Sjögren's syndrome.
    Ou TT; Lin CH; Lin YC; Li RN; Tsai WC; Liu HW; Yen JH
    J Clin Immunol; 2008 Sep; 28(5):440-4. PubMed ID: 18600435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downstream activation of NF-κB in the EDA-A1/EDAR signalling in Sjögren's syndrome and its regulation by the ubiquitin-editing enzyme A20.
    Sisto M; Barca A; Lofrumento DD; Lisi S
    Clin Exp Immunol; 2016 May; 184(2):183-96. PubMed ID: 26724675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A failure of TNFAIP3 negative regulation maintains sustained NF-κB activation in Sjögren's syndrome.
    Sisto M; Lisi S; Lofrumento DD; Ingravallo G; Maiorano E; D'Amore M
    Histochem Cell Biol; 2011 Jun; 135(6):615-25. PubMed ID: 21604024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered phenotype and Stat1 expression in Toll-like receptor 7/8 stimulated monocyte-derived dendritic cells from patients with primary Sjögren's syndrome.
    Vogelsang P; Karlsen M; Brun JG; Jonsson R; Appel S
    Arthritis Res Ther; 2014 Aug; 16(4):R166. PubMed ID: 25113744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated EPSTI1 promote B cell hyperactivation through NF-κB signalling in patients with primary Sjögren's syndrome.
    Sun JL; Zhang HZ; Liu SY; Lian CF; Chen ZL; Shao TH; Zhang S; Zhao LL; He CM; Wang M; Zhang W; Chen H; Zhang FC
    Ann Rheum Dis; 2020 Apr; 79(4):518-524. PubMed ID: 32114510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sjögren's syndrome pathological neovascularization is regulated by VEGF-A-stimulated TACE-dependent crosstalk between VEGFR2 and NF-κB.
    Sisto M; Lisi S; Lofrumento DD; D'Amore M; Frassanito MA; Ribatti D
    Genes Immun; 2012 Jul; 13(5):411-20. PubMed ID: 22513453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulation of chemokine receptor expression and function by B cells of patients with primary Sjögren's syndrome.
    Hansen A; Reiter K; Ziprian T; Jacobi A; Hoffmann A; Gosemann M; Scholze J; Lipsky PE; Dörner T
    Arthritis Rheum; 2005 Jul; 52(7):2109-19. PubMed ID: 15986367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sjögren's syndrome autoantibodies provoke changes in gene expression profiles of inflammatory cytokines triggering a pathway involving TACE/NF-κB.
    Lisi S; Sisto M; Lofrumento DD; D'Amore M
    Lab Invest; 2012 Apr; 92(4):615-24. PubMed ID: 22157716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Regulatory effect of IkappaBalpha on NF-kappaB activity during viral gene transactivation in patients with steroid responsive simple nephrotic syndrome].
    Tao YH; Wang Z; Li CS; Zhu XS
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Mar; 38(2):230-3. PubMed ID: 17441336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A BAFF receptor His159Tyr mutation in Sjögren's syndrome-related lymphoproliferation.
    Papageorgiou A; Mavragani CP; Nezos A; Zintzaras E; Quartuccio L; De Vita S; Koutsilieris M; Tzioufas AG; Moutsopoulos HM; Voulgarelis M
    Arthritis Rheumatol; 2015 Oct; 67(10):2732-41. PubMed ID: 26097183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD40-CD40 ligand signal induces the intercellular adhesion molecule-1 expression through nuclear factor-kappa B p50 in cultured salivary gland epithelial cells from patients with Sjögren's syndrome.
    Saito M; Ota Y; Ohashi H; Dei Y; Shimoyama K; Suzuki D; Hayashi H; Ogawa N
    Mod Rheumatol; 2007; 17(1):45-53. PubMed ID: 17278022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TLR2 signals via NF-κB to drive IL-15 production in salivary gland epithelial cells derived from patients with primary Sjögren's syndrome.
    Sisto M; Lorusso L; Lisi S
    Clin Exp Med; 2017 Aug; 17(3):341-350. PubMed ID: 27260411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNFAIP3 F127C Coding Variation in Greek Primary Sjogren's Syndrome Patients.
    Nezos A; Gkioka E; Koutsilieris M; Voulgarelis M; Tzioufas AG; Mavragani CP
    J Immunol Res; 2018; 2018():6923213. PubMed ID: 30662920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of Fas-ligand mRNA in Sjögren's syndrome patients with enlarged exocrine glands.
    Tsuzaka K; Matsumoto Y; Sasaki Y; Abe T; Tsubota K; Takeuchi T
    Autoimmunity; 2007 Nov; 40(7):497-502. PubMed ID: 17966039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sjögren's syndrome.
    Lavie F; Miceli-Richard C; Ittah M; Sellam J; Gottenberg JE; Mariette X
    Scand J Immunol; 2008 Feb; 67(2):185-92. PubMed ID: 18201372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.